https://www.selleckchem.com/products/rbn-2397.html
Median age at diagnosis was 60 years. Of the 162 patients, 38 patients (28%) had prevalent fractures prior to receiving chemotherapy. Within 1 year after treatment, 16 patients (10%) developed new fractures. Having a prevalent fracture strongly predicted developing a new fracture after treatment, with incident fractures occurring in 12 of 38 patients with prevalent fractures versus 4 of 124 without prevalent fractures (odds ratio 10.45, p0.0005). Our results suggest that patients with aggressive B-cell NHL who receive R-CHOP-like t
Like
Comment
Share
